Brief: Fluidigm Corp - Undertaking A Review Of Various Options, Including With Regard To Strategic Alternatives

Standard BioTools

08/11/2021 21:04

Nov 8 (Reuters) - Fluidigm Corp  FLDM.O :
    * FLUIDIGM ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS
    * SEES Q4 REVENUE ABOUT $31 MILLION TO $34 MILLION
    * Q3 REVENUE $28.5 MILLION
    * UNDERTAKING A REVIEW OF VARIOUS OPTIONS, INCLUDING WITH
REGARD
TO STRATEGIC ALTERNATIVES
    * QTRLY LOSS PER SHARE 18 CENTS

Source text for Eikon:  ID:nGNXczHrK 
Further company coverage:  FLDM.O 

 ((Reuters.Briefs@thomsonreuters.com;))